Studies have also shown that OSAHS patients are accompanied by dyslipidemia, including significantly increased serum levels of TG, TC, very low-density lipoprotein, LDL, and ApoB, and decreased serum levels of HDL and ApoA levels (42). This evidence concerns the gene LPA and metabolic syndrome.